LEADER 01284cam0-22004211i-450- 001 990003988230403321 005 20130710122329.0 010 $a88-348-3123-3 035 $a000398823 035 $aFED01000398823 035 $a(Aleph)000398823FED01 035 $a000398823 100 $a20031217d2003----km-y0itay50------ba 101 0 $aita 102 $aIT 105 $ay---n---011yy 200 1 $a<>contratti di trasporto e di viaggio$fVincenzo Buonocore 210 $aTorino$cGiappichelli$dc2003 215 $aXV, 383 p.$d24 cm 225 1 $aTrattato di diritto commerciale$fdiretto da Vincenzo Buonocore ; [poi] fondato da Vincenzo Buonocore ; diretto da Renzo Costi$v2.3.5 610 0 $aTrasporti 676 $a343.450 93$v21$zita 676 $a346.07 700 1$aBuonocore,$bVincenzo$f<1932-2009>$0132925 801 0$aIT$bUNINA$gRICA$2UNIMARC 901 $aBK 912 $a990003988230403321 952 $a13-AA-123/2,3.V$b12729$fDDCP 952 $aDPR 17/68/3,5$b20906$fDEC 952 $aDPR17/68/3,5bis$b21189$fDEC 952 $aVIII G 311/1 (3.5)$b48264*$fFGBC 952 $a0-3-288-TI$b8323$fECA 959 $aDEC 959 $aFGBC 959 $aECA 959 $aDDCP 996 $aContratti di trasporto e di viaggio$9473970 997 $aUNINA LEADER 01584oam 2200433I 450 001 9910704794803321 005 20131031081745.0 035 $a(CKB)5470000002443773 035 $a(OCoLC)861751591 035 $a(OCoLC)995470000002443773 035 $a(EXLCZ)995470000002443773 100 $a20131030d2013 ua 0 101 0 $aeng 135 $aurcn||||||||| 181 $2rdacontent 182 $2rdamedia 183 $2rdacarrier 200 10$aProcedure for calculating estimated ultimate recoveries of Bakken and Three Forks Formations horizontal wells in the Williston Basin /$fby Troy A. Cook 210 1$aReston, Virginia :$cU.S. Department of the Interior, U.S. Geological Survey,$d2013. 215 $a1 online resource (iv, 14 pages) $ccolor illustrations 225 1 $aOpen-file report ;$v2013-1109 300 $aTitle from title screen (viewed on Oct. 28, 2013). 320 $aIncludes bibliographical references (page 14). 606 $aOil well logging$xMeasurement 606 $aPetroleum$xMeasurement 607 $aWilliston Basin 607 $aBakken Formation 607 $aThree Forks (Mont.) 615 0$aOil well logging$xMeasurement. 615 0$aPetroleum$xMeasurement. 700 $aCook$b Troy A.$01403158 712 02$aGeological Survey (U.S.), 801 0$bGPO 801 1$bGPO 801 2$bGPO 906 $aBOOK 912 $a9910704794803321 996 $aProcedure for calculating estimated ultimate recoveries of Bakken and Three Forks Formations horizontal wells in the Williston Basin$93481826 997 $aUNINA LEADER 03504oam 2200865zu 450 001 9910830718003321 005 20230614123752.0 010 $a0-470-51042-0 010 $a0-470-51041-2 035 $a(CKB)1000000000377338 035 $a(SSID)ssj0000354626 035 $a(PQKBManifestationID)11272620 035 $a(PQKBTitleCode)TC0000354626 035 $a(PQKBWorkID)10302389 035 $a(PQKB)10120943 035 $a(EXLCZ)991000000000377338 100 $a20160829d2007 uy 101 0 $aeng 181 $ctxt 182 $cc 183 $acr 200 10$aPharmacotherapy of bipolar disorders 210 31$a[Place of publication not identified]$cJohn Wiley & Sons Ltd$d2007 300 $aBibliographic Level Mode of Issuance: Monograph 311 $a0-470-05823-4 327 $aEpidemiology of bipolar disorders -- Classification of bipolar disorders -- How to define a mood stabilizer -- Lithium -- Carbamazepine -- Lamotrigine -- Topiramate -- Valproic acid -- The role of atypical or second generation antipsychotics -- Other medications used for bipolar disorders -- Medications that may potentially induce a depressive state -- Medications that may potentially induce a (hypo)manic syndrome -- Maintenance treatment : when should a long-term treatment be introduced -- Treatment of the depressive phase of bipolar disorders -- Treatment of bipolar II disorder -- Treatment of manic phases -- Treatment of rapid cycling -- Treatment of mixed states -- Combination treatments -- Bipolar disorders, pregnancy and breastfeeding -- Bipolar disorders in children and adolescents -- Bipolar disorders in geriatric patients. 606 $aBipolar disorder$xChemotherapy 606 $aAntimanic Agents 606 $aBipolar Disorder 606 $aDrug Therapy 606 $aTranquilizing Agents 606 $aTherapeutics 606 $aAffective Disorders, Psychotic 606 $aPsychotropic Drugs 606 $aCentral Nervous System Depressants 606 $aMood Disorders 606 $aPhysiological Effects of Drugs 606 $aMental Disorders 606 $aCentral Nervous System Agents 606 $aPharmacologic Actions 606 $aTherapeutic Uses 606 $aChemical Actions and Uses 606 $aPsychiatric Disorders, Individual$2HILCC 606 $aPsychiatry$2HILCC 606 $aHealth & Biological Sciences$2HILCC 615 0$aBipolar disorder$xChemotherapy 615 2$aAntimanic Agents 615 2$aBipolar Disorder 615 2$aDrug Therapy 615 2$aTranquilizing Agents 615 2$aTherapeutics 615 2$aAffective Disorders, Psychotic 615 2$aPsychotropic Drugs 615 2$aCentral Nervous System Depressants 615 2$aMood Disorders 615 2$aPhysiological Effects of Drugs 615 2$aMental Disorders 615 2$aCentral Nervous System Agents 615 2$aPharmacologic Actions 615 2$aTherapeutic Uses 615 2$aChemical Actions and Uses 615 7$aPsychiatric Disorders, Individual 615 7$aPsychiatry 615 7$aHealth & Biological Sciences 676 $a616.89/5061 700 $aAubry$b Jean-Michel$01606768 702 $aAubry$b Jean-Michel 702 $aSchaad$b Nicolas 702 $aFerrero$b François-P 702 $aFerrero$b Franðcois-P 801 0$bPQKB 906 $aBOOK 912 $a9910830718003321 996 $aPharmacotherapy of bipolar disorders$93932724 997 $aUNINA